Skip to main content

Table 3 Patients and VAA characteristics according to the period of treatment

From: Visceral artery aneurysms: evolving interdisciplinary management and future role of the abdominal surgeon

N of patients

Before 2013

Since 2013

 

17

25

 

Age median (range)

71 (47–91)

58 (30–80)

P = 0.01

Female n (%)

6 (35%)

13 (52%)

P = 0.29

Male n (%)

11 (65%)

12 (48%)

 

Diameter in cm mean (SD)

2.9 (± 1.5)

2.6 (± 1.5)

P = 0.52

Symptoms n (%)

11 (65%)

14 (41%)

P = 0.57

 Abdominal pain n (%)

3 (18%)

5 (15%)

P = 0.65

 Intraabdominal hemorrhage n (%)

8 (47%)

9 (26%)

 

N of aneurysms

22

34

 

 Splenic artery n (%)

5 (23%)

13 (38%)

P = 0.76

 Hepatic artery n (%)

6 (27%)

7 (21%)

 

 Superior mesenteric artery n (%)

5 (23%)

4 (12%)

 

 Gastroduodenalis artery n (%)

3 (14%)

6 (18%)

 

 Left gastric artery n (%)

2 (9%)

2 (6%)

 

 Celiac trunk n (%)

1 (5%)

2 (6%)

 

 N of true aneurysms

6 (27%)

26 (76%)

P = 0.0006

 N of pseudoaneurysms

13 (59%)

8 (24%)

 

 Indetermined morphology

3 (14%)

0 (0%)

 

Operation n (%)

8 (47%)

3 (12%)

P = 0.017

Intervention n (%)

9 (53%)

20 (80%)

 

 Coiling n (%)

7 (41%)

16 (64%)

P = 0.45

 Stenting n (%)

2 (12%)

2 (8%)

 

 Stenting + coiling n (%)

0 (0%)

2 (8%)

 

No operation/intervention n (%)

0 (0%)

2 (8%)

P = 0.23

Emergency

8 (47%)

9 (36%)

P = 0.62

Elective

9 (53%)

14 (56%)

 

Complications n (%)

9 (53%)

8 (32%)

P = 0.17

 Dindo 1

0 (0%)

2 (8%)

P = 0.25

 Dindo 2

6 (35%)

2 (8%)

 

 Dindo 3

2 (12%)

3 (12%)

 

 Dindo 4

1 (6%)

1 (4%)

 

Median hospital stay in days (range)

16 (1–238)

13 (2–122)

P = 0.61

Median follow-up in months (range)

37 (0–151)

7 (0–46)

P = 0.0007

N of deceased patients

2 (12%)

7 (28%)

P = 0.21

  1. VAA visceral artery aneurysm, SD standard deviation
  2. Italic values indicate statistical significance (P<0.05)